![](https://news.europawire.eu/wp-content/uploads/2024/04/AstraZenecas-IMPACT-CKD-Model-Forecasts-Alarming-Rise-in-Chronic-Kidney-Disease-by-2032-144x144.jpg)
(IN BRIEF) AstraZeneca’s IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up to 16.5% of the population affected by 2032, including a substantial rise in advanced-stage cases. Presented at the 2024 ISN … Read the full press release